These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

836 related articles for article (PubMed ID: 18087165)

  • 1. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
    Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Yamamoto H; Kunii N; Sakurai D; Fujimura T; Nakazawa K; Yasueda H
    Int Arch Allergy Immunol; 2008; 146(1):76-84. PubMed ID: 18087165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
    Nakai Y; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Masamoto T; Yamada K; Nakai Y; Ohmoto Y
    Acta Otolaryngol Suppl; 1998; 538():143-51. PubMed ID: 9879414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seasonal changes in antigen-specific T-helper clone sizes in patients with Japanese cedar pollinosis: a 2-year study.
    Horiguchi S; Tanaka Y; Uchida T; Chazono H; Ookawa T; Sakurai D; Okamoto Y
    Clin Exp Allergy; 2008 Mar; 38(3):405-12. PubMed ID: 18070160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-allergic potential of oligomannose-coated liposome-entrapped Cry j 1 as immunotherapy for Japanese cedar pollinosis in mice.
    Ishii M; Koyama A; Iseki H; Narumi H; Yokoyama N; Kojima N
    Int Immunopharmacol; 2010 Sep; 10(9):1041-6. PubMed ID: 20584630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of human T cell epitopes in Japanese cypress pollen allergen, Cha o 1, elucidates the intrinsic mechanism of cross-allergenicity between Cha o 1 and Cry j 1, the major allergen of Japanese cedar pollen, at the T cell level.
    Sone T; Dairiki K; Morikubo K; Shimizu K; Tsunoo H; Mori T; Kino K
    Clin Exp Allergy; 2005 May; 35(5):664-71. PubMed ID: 15898991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of carbohydrates on Cry j 1, the major allergen of Japanese cedar pollen, in specific T-cell responses.
    Okano M; Kino K; Takishita T; Hattori H; Ogawa T; Yoshino T; Yokoyama M; Nishizaki K
    J Allergy Clin Immunol; 2001 Jul; 108(1):101-8. PubMed ID: 11447389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
    Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
    Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
    Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Kunii N; Yamamoto H; Sakurai D; Hanazawa T
    Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antigen specific sublingual immunotherapy for pediatric Japanese cedar pollinosis].
    Yuta A; Miyamoto Y; Ogihara H; Hattori R; Okubo K
    Arerugi; 2009 Feb; 58(2):124-32. PubMed ID: 19329875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evaluation of an immunotherapeutic peptide comprising 7 T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen allergens.
    Hirahara K; Tatsuta T; Takatori T; Ohtsuki M; Kirinaka H; Kawaguchi J; Serizawa N; Taniguchi Y; Saito S; Sakaguchi M; Inouye S; Shiraishi A
    J Allergy Clin Immunol; 2001 Jul; 108(1):94-100. PubMed ID: 11447388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
    Panzner P; Petrás M; Sýkora T; Lesná I
    Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA vaccination against Japanese cedar pollinosis in dogs suppresses type I hypersensitivity by controlling lesional mast cells.
    Masuda K
    Vet Immunol Immunopathol; 2005 Oct; 108(1-2):185-7. PubMed ID: 16098609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotics in the treatment of Japanese cedar pollinosis: a double-blind placebo-controlled trial.
    Xiao JZ; Kondo S; Yanagisawa N; Takahashi N; Odamaki T; Iwabuchi N; Miyaji K; Iwatsuki K; Togashi H; Enomoto K; Enomoto T
    Clin Exp Allergy; 2006 Nov; 36(11):1425-35. PubMed ID: 17083353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I/II study of oral immunotherapy with Cry j1-galactomannan conjugate for Japanese cedar pollinosis.
    Murakami D; Kubo K; Sawatsubashi M; Kikkawa S; Ejima M; Saito A; Kato A; Komune S
    Auris Nasus Larynx; 2014 Aug; 41(4):350-8. PubMed ID: 24698163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of a new regimen of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: a prospective, randomized, open-label study.
    Murakami D; Sawatsubashi M; Kikkawa S; Ejima M; Saito A; Kato A; Komune S
    Allergol Int; 2015 Apr; 64(2):161-8. PubMed ID: 25838092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effects of immunotherapy on Japanese cedar pollinosis in the season of cedar and cypress pollination.
    Ito Y; Takahashi Y; Fujita T; Fukuyama S
    Auris Nasus Larynx; 1997 Apr; 24(2):163-70. PubMed ID: 9134139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide immunotherapy for allergic diseases using a rice-based edible vaccine.
    Hiroi T; Takaiwa F
    Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):455-60. PubMed ID: 17088651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract.
    Amar SM; Harbeck RJ; Sills M; Silveira LJ; O'Brien H; Nelson HS
    J Allergy Clin Immunol; 2009 Jul; 124(1):150-156.e1-5. PubMed ID: 19523672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of regulatory T cells and the ratio of specific IgE to total IgE are candidates for response monitoring or prognostic biomarkers in 2-year sublingual immunotherapy (SLIT) for Japanese cedar pollinosis.
    Fujimura T; Yonekura S; Horiguchi S; Taniguchi Y; Saito A; Yasueda H; Inamine A; Nakayama T; Takemori T; Taniguchi M; Sakaguchi M; Okamoto Y
    Clin Immunol; 2011 Apr; 139(1):65-74. PubMed ID: 21300571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
    Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
    Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.